Advanced search
Combine gene, variant, phenotype, region and year filters
Every result shows the extracted entities next to the sentences that support them; rows for the searched entities come first.
Transparent by designEvery result links extracted entities to its source sentence and publication identifier.
Knowledge-base search
About your search
ABO and diabetes mellitus are reported together in 2 articles.
Gene
ABO
- HGNC
- HGNC:79
20articles
20mentions
1variants with confirmed gene link
Most co-reported phenotypes (articles)
COVID-19 5SARS 2diabetes mellitus 2hypertension 2coronary artery disease 1leukemia 1malaria 1stroke 1
Reported variants (articles · ClinVar status)
Phenotype
Diabetes mellitus
2,156articles
2,156mentions
12co-reported genes shown
Most co-reported genes (articles)
Counts are literature co-mentions in SaudiVarKB, not clinical or causal assertions. Gene details: HGNC; variant status: ClinVar via dbSNP.
Publications
2 records shown · first 60Association of HLA-B gene polymorphism and blood groups with COVID-19 susceptibility and severity.
PMID 40877359 | PMCID PMC12394550 | DOI 10.1038/s41598-025-15455-1 · Scientific reports · 2025 · 5 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ABO | “Among these, the HLA polymorphisms and ABO blood groups are known to influence the immune system.” | 0.98 | hgnc_dict_v1 |
| phenotype | diabetes mellitus | “A strong correlation was observed between co-morbidities (hypertension, diabetes) and severe COVID-19 outcomes.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | HLA-B | “Association of HLA-B gene polymorphism and blood groups with COVID-19 susceptibility and severity.” | 0.98 | hgnc_dict_v1 |
| phenotype | COVID-19 | “Association of HLA-B gene polymorphism and blood groups with COVID-19 susceptibility and severity.” | 0.98 | phenotype_alias_lexicon_v2 |
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.
PMID 25631608 | PMCID PMC4311266 | DOI 10.1038/ncomms6897 · Nature communications · 2015 · 7 validated mentions
Evidence preview
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| gene | ABO | “We identify rs651007 (MAF=20%) in the first intron of ABO at the putative promoter of an antisense lncRNA, associating with higher FG (β=0.02±0.004 mmol l(-1), P=1.3 × 10(-8)).” | 0.98 | hgnc_dict_v1 |
| phenotype | diabetes mellitus | “Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.” | 0.93 | phenotype_alias_lexicon_v2 |
| gene | GLP1R | “We identify a novel association of a low-frequency nonsynonymous SNV in GLP1R (A316T; rs10305492; MAF=1.4%) with lower FG (β=-0.09±0.01 mmol l(-1), P=3.4 × 10(-12)), T2D risk (OR[95%CI]=0.86[0.76-0.96], P=0.010), early insulin secretion (β=-0.07±0.035 pmolinsulin mmolglucose(-1), P=0.048), but higher 2-h glucose (β=0.16±0.05 mmol l(-1), P=4.3 × 10(-4)).” | 0.98 | hgnc_dict_v1 |
| gene | MAF | “We identify a novel association of a low-frequency nonsynonymous SNV in GLP1R (A316T; rs10305492; MAF=1.4%) with lower FG (β=-0.09±0.01 mmol l(-1), P=3.4 × 10(-12)), T2D risk (OR[95%CI]=0.86[0.76-0.96], P=0.010), early insulin secretion (β=-0.07±0.035 pmolinsulin mmolglucose(-1), P=0.048), but higher 2-h glucose (β=0.16±0.05 mmol l(-1), P=4.3 × 10(-4)).” | 0.98 | hgnc_dict_v1 |